Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Other Non Operating Income (2017 - 2025)

PAVmed has reported Other Non Operating Income over the past 5 years, most recently at -$58000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 96.2% year-over-year to -$58000.0; the TTM value through Sep 2025 reached -$1.5 million, changed N/A, while the annual FY2024 figure was -$2.5 million, 75.78% up from the prior year.
  • Other Non Operating Income for Q4 2025 was -$58000.0 at PAVmed, down from $58000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $5.4 million in Q3 2021 and troughed at -$6.6 million in Q3 2022.
  • A 5-year average of -$1.1 million and a median of -$58000.0 in 2025 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: crashed 90750.0% in 2023 and later skyrocketed 180.38% in 2024.
  • Year by year, Other Non Operating Income stood at $5.4 million in 2021, then tumbled by 99.47% to $29000.0 in 2022, then plummeted by 3634.48% to -$1.0 million in 2023, then tumbled by 48.88% to -$1.5 million in 2024, then soared by 96.2% to -$58000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for PAVM at -$58000.0 in Q4 2025, $58000.0 in Q1 2025, and -$1.5 million in Q4 2024.